Lftd Partners Inc. (LIFD): Operating Income
$913.2K
Year ended 2025-12-31
-$4.74M
Trailing 12 months to 2026-06-30
-54.7%
3-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $913.2K | n/m | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | -$773.5K | n/m | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $2.41M | -75.4% | 2026-04-01, From 2023-01-01 |
| 2022-12-31 | $9.81M | +26.1% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | $7.78M | n/m | 2024-03-29, From 2021-01-01 |
| 2020-12-31 | -$1.52M | n/m | 2023-03-21, From 2020-01-01 |
| 2019-12-31 | -$1.26M | n/m | 2022-03-31, From 2019-01-01 |
| 2018-12-31 | -$181.6K | n/a | 2020-03-30, From 2018-01-01 |
| No annual figure between 2012-12-31 and 2018-12-31. | |||
| 2012-12-31 | -$1.25M | n/m | 2013-04-01, From 2012-01-01 |
| 2011-12-31 | -$208.2K | n/m | 2013-04-01, From 2011-01-01 |
| 2010-12-31 | -$124.1K | n/a | 2012-03-30, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $913.2K | n/m |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | -$6.23M | n/m |
| BGM Group Ltd. (BGM) | 2025-09-30 | -$12.58M | n/m |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | -$12.19M | n/m |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | -$5.58M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$11.35M | n/m |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | -$84.35M | n/m |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | -$215.38M | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$41.98M | n/m |
Compare LIFD, SBFM, BGM, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗